AAAAAA

   
Results: 1-25 | 26-50 | 51-71
Results: 1-25/71
ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION
Authors: GRIESE EU ZANGER UM BRUDERMANNS U GAEDIGK A MIKUS G MORIKE K STUVEN T EICHELBAUM M
Citation: Eu. Griese et al., ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION, Pharmacogenetics, 8(1), 1998, pp. 15-26
GUT WALL METABOLISM OF VERAPAMIL IN OLDER-PEOPLE - EFFECTS OF RIFAMPICIN-MEDIATED ENZYME-INDUCTION
Authors: FROMM MF DILGER K BUSSE D KROEMER HK EICHELBAUM M KLOTZ U
Citation: Mf. Fromm et al., GUT WALL METABOLISM OF VERAPAMIL IN OLDER-PEOPLE - EFFECTS OF RIFAMPICIN-MEDIATED ENZYME-INDUCTION, British journal of clinical pharmacology, 45(3), 1998, pp. 247-255
SAME INCIDENCE OF ADVERSE DRUG EVENTS AFTER CODEINE ADMINISTRATION IRRESPECTIVE OF THE GENETICALLY-DETERMINED DIFFERENCES IN MORPHINE FORMATION
Authors: ECKHARDT K LI SX AMMON S SCHANZLE G MIKUS G EICHELBAUM M
Citation: K. Eckhardt et al., SAME INCIDENCE OF ADVERSE DRUG EVENTS AFTER CODEINE ADMINISTRATION IRRESPECTIVE OF THE GENETICALLY-DETERMINED DIFFERENCES IN MORPHINE FORMATION, Pain, 76(1-2), 1998, pp. 27-33
DENGLER,HANS,J - IN-MEMORIAM
Authors: SJOQVIST F EICHELBAUM M DAHLQVIST R
Citation: F. Sjoqvist et al., DENGLER,HANS,J - IN-MEMORIAM, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 495-495
A DISTRIBUTION STUDY OF CYP1A2 PHENOTYPES AMONG SMOKERS AND NONSMOKERS IN A COHORT OF HEALTHY CAUCASIAN VOLUNTEERS
Authors: SCHRENK D BROCKMEIER D MORIKE K BOCK KW EICHELBAUM M
Citation: D. Schrenk et al., A DISTRIBUTION STUDY OF CYP1A2 PHENOTYPES AMONG SMOKERS AND NONSMOKERS IN A COHORT OF HEALTHY CAUCASIAN VOLUNTEERS, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 361-367
ANALYSIS OF CYP2C8, CYP2C9, CYP2C18 AND CYP2C19 MESSENGER-RNA EXPRESSION IN HUMAN LIVER, SMALL-INTESTINE, SKIN AND LEUKOCYTES
Authors: LAEPPLE F GRIESE EU ZANGER U THON KP EICHELBAUM M
Citation: F. Laepple et al., ANALYSIS OF CYP2C8, CYP2C9, CYP2C18 AND CYP2C19 MESSENGER-RNA EXPRESSION IN HUMAN LIVER, SMALL-INTESTINE, SKIN AND LEUKOCYTES, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 74-74
THE ENANTIOMER VERSUS RACEMATE DEBATE - A CLINICAL PERSPECTIVE
Authors: EICHELBAUM M
Citation: M. Eichelbaum, THE ENANTIOMER VERSUS RACEMATE DEBATE - A CLINICAL PERSPECTIVE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 15-15
DISTRIBUTION OF CYP2D6 MESSENGER-RNA AND PROTEIN IN EXTRAHEPATIC HUMAN TISSUES - A STUDY BY IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY
Authors: SIEGLE I FRITZ P EICHELBAUM M ZANGER UM
Citation: I. Siegle et al., DISTRIBUTION OF CYP2D6 MESSENGER-RNA AND PROTEIN IN EXTRAHEPATIC HUMAN TISSUES - A STUDY BY IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 438-438
PHARMACOKINETIC INTERACTION BETWEEN DIGOXIN AND RIFAMPIN - THE ROLE OF P-GLYCOPROTEIN
Authors: GREINER B VONRICHTER O FRITZ P ZUNDLER J KREICHGAUER HP KROEMER HK EICHELBAUM M
Citation: B. Greiner et al., PHARMACOKINETIC INTERACTION BETWEEN DIGOXIN AND RIFAMPIN - THE ROLE OF P-GLYCOPROTEIN, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4729-4729
THE FATE OF NARINGIN, OF COUMARIN, AND OF NARINGIN PLUS COUMARIN IN MAN - WHERE OCCUR INTERACTIONS
Authors: GREINER B VONRICHTER O FRITZ P ZUNDLER J KREICHGAUER HP KROEMER HK EICHELBAUM M
Citation: B. Greiner et al., THE FATE OF NARINGIN, OF COUMARIN, AND OF NARINGIN PLUS COUMARIN IN MAN - WHERE OCCUR INTERACTIONS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4731-4731
A RAPID, HIGHLY SENSITIVE HPLC MASS-SPECTROMETRIC METHOD FOR THE DETERMINATION OF MORPHINE AND ITS METABOLITES - APPLICATION TO PHARMACOKINETIC STUDIES
Authors: SCHANZLE G LI S FROMM MF ECKHARDT K HOFMANN U MIKUS G EICHELBAUM M
Citation: G. Schanzle et al., A RAPID, HIGHLY SENSITIVE HPLC MASS-SPECTROMETRIC METHOD FOR THE DETERMINATION OF MORPHINE AND ITS METABOLITES - APPLICATION TO PHARMACOKINETIC STUDIES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4816-4816
MARKED DECREASE OF DIGOXIN BIOAVAILABILITY BY RIFAMPIN
Authors: GREINER B FRITZ P ZUNDLER J KREICHGAUER HP KROEMER HK EICHELBAUM M
Citation: B. Greiner et al., MARKED DECREASE OF DIGOXIN BIOAVAILABILITY BY RIFAMPIN, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 622-622
PHARMACOKINETICS AND PHARMACODYNAMICS OF PLACEBO-CONTROLLED SINGLE RISING ORAL DOSES OF VERAPAMIL, S-VERAPAMIL AND R-VERAPAMIL
Authors: ECKERT S MIKUS G HOFMANN U EICHELBAUM M
Citation: S. Eckert et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF PLACEBO-CONTROLLED SINGLE RISING ORAL DOSES OF VERAPAMIL, S-VERAPAMIL AND R-VERAPAMIL, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 667-667
OCULAR PHARMACOKINETICS OF VERAPAMIL IN RABBITS
Authors: ETTL A HOFMANN U DAXER A DIETRICH H SCHMID E EICHELBAUM M
Citation: A. Ettl et al., OCULAR PHARMACOKINETICS OF VERAPAMIL IN RABBITS, Naunyn-Schmiedeberg's archives of pharmacology, 357(3), 1998, pp. 331-335
EXPECTATION TRAPS AND DISCRETION
Authors: CHARI VV CHRISTIANO LJ EICHELBAUM M
Citation: Vv. Chari et al., EXPECTATION TRAPS AND DISCRETION, Journal of economic theory (Print), 81(2), 1998, pp. 462-492
IN-MEMORIAM PROFESSOR DR. MED. DENGLER,HA NS,J
Authors: EICHELBAUM M VONBERGMANN K
Citation: M. Eichelbaum et K. Vonbergmann, IN-MEMORIAM PROFESSOR DR. MED. DENGLER,HA NS,J, Arzneimittel-Forschung, 48(4), 1998, pp. 415-416
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF ACROLEIN AS A MARKER FOR CYCLOPHOSPHAMIDE BIOACTIVATION IN HUMAN LIVER-MICROSOMES
Authors: BOHNENSTENGEL F EICHELBAUM M GOLBS E KROEMER HK
Citation: F. Bohnenstengel et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF ACROLEIN AS A MARKER FOR CYCLOPHOSPHAMIDE BIOACTIVATION IN HUMAN LIVER-MICROSOMES, Journal of chromatography B. Biomedical sciences and applications, 692(1), 1997, pp. 163-168
DOSE-ESCALATION OF CYCLOPHOSPHAMIDE IN PATIENTS WITH BREAST-CANCER - CONSEQUENCES FOR PHARMACOKINETICS AND METABOLISM
Authors: BUSSE D BUSCH FW BOHNENSTENGEL F EICHELBAUM M FISCHER P OPALINSKA J SCHUMACHER K SCHWEIZER E KROEMER HK
Citation: D. Busse et al., DOSE-ESCALATION OF CYCLOPHOSPHAMIDE IN PATIENTS WITH BREAST-CANCER - CONSEQUENCES FOR PHARMACOKINETICS AND METABOLISM, Journal of clinical oncology, 15(5), 1997, pp. 1885-1896
LOSS OF ANALGESIC EFFECT OF MORPHINE DUE COADMINISTRATION OF RIFAMPIN
Authors: FROMM MF ECKHARDT K LI SX SCHANZLE G HOFMANN U MIKUS G EICHELBAUM M
Citation: Mf. Fromm et al., LOSS OF ANALGESIC EFFECT OF MORPHINE DUE COADMINISTRATION OF RIFAMPIN, Pain, 72(1-2), 1997, pp. 261-267
IMPACT OF P450 GENETIC-POLYMORPHISM ON THE FIRST-PASS EXTRACTION OF CARDIOVASCULAR AND NEUROACTIVE DRUGS
Authors: FROMM MF KROEMER HK EICHELBAUM M
Citation: Mf. Fromm et al., IMPACT OF P450 GENETIC-POLYMORPHISM ON THE FIRST-PASS EXTRACTION OF CARDIOVASCULAR AND NEUROACTIVE DRUGS, Advanced drug delivery reviews, 27(2-3), 1997, pp. 171-199
CONSEQUENCES OF POLYMORPHIC DRUG-METABOLISM FOR DRUG TOXICITY
Authors: EICHELBAUM M
Citation: M. Eichelbaum, CONSEQUENCES OF POLYMORPHIC DRUG-METABOLISM FOR DRUG TOXICITY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 21-21
CHRONOPHARMACOKINETIC AND CHRONOPHARMACO-DYNAMIC INVESTIGATION OF A NEW VERAPAMIL MODIFIED RELEASE FORMULATION
Authors: ECKHARDT K DILGER K EICHELBAUM M KUCHER K MIKUS G
Citation: K. Eckhardt et al., CHRONOPHARMACOKINETIC AND CHRONOPHARMACO-DYNAMIC INVESTIGATION OF A NEW VERAPAMIL MODIFIED RELEASE FORMULATION, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 445-445
A DRUG-THERAPY INFORMATION-SERVICE FOR PRACTITIONERS IN NORTHERN WURTTEMBERG - FIRST EXPERIENCES WITH A HOTLINE
Authors: MORIKE K SCHWAB M MIKUS G BOSEN N EICHELBAUM M
Citation: K. Morike et al., A DRUG-THERAPY INFORMATION-SERVICE FOR PRACTITIONERS IN NORTHERN WURTTEMBERG - FIRST EXPERIENCES WITH A HOTLINE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 447-447
DIFFERENT APPLICATION SCHEDULES OF HIGH-DOSE CYCLOPHOSPHAMIDE - INFLUENCE ON KINETICS AND METABOLISM
Authors: BUSSE D BUSCH FW BOHNENSTENGEL F EICHELBAUM M FISCHER P SCHUMACHER K SCHWEIZER E KROEMER HK
Citation: D. Busse et al., DIFFERENT APPLICATION SCHEDULES OF HIGH-DOSE CYCLOPHOSPHAMIDE - INFLUENCE ON KINETICS AND METABOLISM, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 449-449
IMMUNOHISTOCHEMICAL ASSESSMENT OF CYP2D6 EXPRESSION IN NORMAL HUMAN TISSUE
Authors: ZANGER UM FRITZ P BEHRLE E FRIEDEL A KIVISTO K EICHELBAUM M
Citation: Um. Zanger et al., IMMUNOHISTOCHEMICAL ASSESSMENT OF CYP2D6 EXPRESSION IN NORMAL HUMAN TISSUE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 456-456
Risultati: 1-25 | 26-50 | 51-71